Current issue
Archive
Online first
About the Journal
Editorial Board
Scientific Board
Reviewers
Abstracting and indexing
Publisher
Contact
Subscription
Ethical standards and procedures
Abstracting and indexing
For authors
Ethical standards and procedures
Publication charge
Books and Events
Books
Events
RESEARCH PAPER
Secondary Glaucoma Following Radiation Therapy for Head and Neck Cancers
1
Kornel Gibiński University Clinical Center, Medical University of Silesia in Katowice, Poland
2
Department of Radiotherapy and Oncology, Faculty of Medical Sciences in Zabrze, Medical University of Silesia in Katowice, Poland
3
Clinical Department of Ophthalmology, Faculty of Medical Sciences in Katowice, Medical University of Silesia in Katowice, Poland
Submission date: 2025-08-06
Acceptance date: 2025-08-19
Publication date: 2025-11-06
Ophthalmology 2025;28(2):22-24
KEYWORDS
ABSTRACT
Radiation therapy is an important treatment modality; however, despite major technological advances in its planning and delivery, it still carries the risk of side effects. Although radiation-induced complications are well documented in the literature, the authors believe that secondary glaucoma associated with head and neck radiation therapy remains notably underrepresented. This serious condition can result not only in irreversible vision loss but may also require enucleation of the affected eye. To reduce such risks, active collaboration between oncologists, radiotherapists, and ophthalmologists is essential. In this article, the authors examine the causes and management of secondary glaucoma following radiation therapy.
REFERENCES (27)
1.
Barton MB, Jacob S, Shafiq J, et al.: Estimating the demand for radiotherapy from the evidence: a review of changes from 2003 to 2012. Radiother Oncol. 2014; 112: 140–144.
2.
Saloura V, Langerman A, Rudra S, et al.: Multidisciplinary care of the patient with head and neck cancer. Surg Oncol Clin N Am. 2013; 22: 179–215.
3.
van der Molen L, van Rossum MA, Burkhead LM, et al.: Functional outcomes and rehabilitation strategies in patients treated with chemoradiotherapy for advanced head and neck cancer: a systematic review. Eur Arch Otorhinolaryngol. 2009; 266: 889–900.
4.
Filarska D, Czyżewska K: Uszkodzenie narządu wzroku po radioterapii – przegląd literatury. Współczesna Onkologia. 2000; vol. 4; 3: 109–110.
5.
Zemba M, Dumitrescu OM, Gheorghe AG, et al.: Ocular Complications of Radiotherapy in Uveal Melanoma. Cancers. 2023; 15(2): 333.
6.
Wen JC, Oliver S, McCannel TA: Ocular complications following I-125 brachytherapy for choroidal melanoma. Eye. 2009; 23: 1254–1268.
7.
Groenewald C, Konstantinidis L, Damato B: Effects of radiotherapy on uveal melanomas and adjacent tissues. Eye. 2012; 27: 163–171.
8.
Gopalakrishna M, Srinivasan K, Rengaraj V: Radiation-induced neovascular glaucoma: A devastating disease. J Can Res Ther. 2020; 16: S213–216.
9.
Kim EA, Salazar D, McCannel CA, et al.: Glaucoma After Iodine-125 Brachytherapy for Uveal Melanoma: Incidence and Risk Factors. J Glaucoma. 2020 Jan; 29(1): 1–10.
10.
Takeda A, Shigematsu N, Suzuki S, et al.: Late retinal complications of radiation therapy for nasal and paranasal malignancies: relationship between irradiated-dose area and severity. Int J Radiat Oncol Biol Phys. 1999; 44: 599–605.
11.
Alterioa D, Marvasoa G, Ferrari A, et al.: Modern radiotherapy for head and neck cancer. Seminars in Oncology. 2019 June; Volume 46, Issue 3.
14.
Ziółkowska E, Zarzycka M, Meller A, et al.: Powikłania oczne po radioterapii nowotworów regionu głowy i szyi – przegląd piśmiennictwa. Współczesna Onkologia. 2009; vol. 13; 5: 251–254.
15.
Foster PJ, Buhrmann R, Quigley HA, et al.: The definition and classification of glaucoma in prevalence surveys. Br J Ophthalmol. 2002; 86 (2): 238–242, doi: 10.1136/bjo.86.2.238.
17.
Puusaari I, Heikkonen J, Kivelä T: Ocular complications after iodine brachytherapy for large uveal melanomas. Ophthalmology. 2004; 111: 1768– –1777.
18.
Detorakis ET, Engstrom RE, Wallace R, et al.: Iris and anterior chamber angle neovascularization after iodine 125 brachytherapy for uveal melanoma. Ophthalmology. 2005; 112: 505–510.
19.
Brour J, Desjardins L, Lehoang P, et al.: Sympathetic Ophthalmia after Proton Beam Irradiation for Choroïdal Melanoma. Ocul Immunol Inflamm. 2012; 20: 273–276.
20.
Riechardt AI, Cordini D, Rehak M, et al.: Trabeculectomy in patients with uveal melanoma after proton beam therapy. Graefe’s Arch Clin Exp Ophthalmol. 2016; 254: 1379–1385.
21.
Sharkawi E, Oleszczuk JD, Bergin C, et al.: Baerveldt shunts in the treatment of glaucoma secondary to anterior uveal melanoma and proton beam radiotherapy. Br J Ophthalmol. 2012; 96: 1104–1107.
22.
Seibel I, Riechardt AI, Heufelder J, et al.: Adjuvant Ab Interno Tumor Treatment After Proton Beam Irradiation. Am J Ophthalmol. 2017; 178: 94–100.
23.
Lumbroso L, Desjardins L, Levy C, et al.: Intraocular Inflammation after Proton Beam Irradiation for Uveal Melanoma. Br J Ophthalmol. 2001; 85: 1305–1308.
24.
Fries PD, Char DH, Crawford JB, et al.: Sympathetic ophthalmia complicating helium ion irradiation of a choroidal melanoma. Arch Ophthalmol. 1987; 105: 1561±4.= 1561–1564.
25.
Foti PV, Travali M, Farina R, et al.: Diagnostic Methods and Therapeutic Options of Uveal Melanoma with Emphasis on MR Imaging – Part II: Treatment Indications and Complications. Insights Imaging. 2021; 12: 67.
26.
Hager A, Meissner F, Riechardt AI, et al.: Breakdown of the Blood-Eye Barrier in Choroidal Melanoma after Proton Beam Radiotherapy. Graefes Arch Clin Exp Ophthalmol. 2019; 257: 2323–2328.
27.
Mahdjoubi A, Najean M, Lemaitre S, et al.: Intravitreal bevacizumab for neovascular glaucoma in uveal melanoma treated by proton beam therapy. Graefe’s Arch Clin Exp Ophthalmol. 2017; 256: 411–420.
Share
RELATED ARTICLE
| eISSN: | 1689-362X |
| ISSN: | 1505-2753 |
We process personal data collected when visiting the website. The function of obtaining information about users and their behavior is carried out by voluntarily entered information in forms and saving cookies in end devices. Data, including cookies, are used to provide services, improve the user experience and to analyze the traffic in accordance with the Privacy policy. Data are also collected and processed by Google Analytics tool (more).
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
